Province opens eligibility to new drug to help those with cystic fibrosis

The province of Saskatchewan has announced that it is expanding the eligibility of those living with cystic fibrosis (CF) to a medication which improves lung function. Opening up eligibility People in Saskatchewan will now be able to take Alyftrek, a medication available for those ages six years and older who meet the medical criteria. The drug will be used for patients who have one of the 266 different genetic mutations which cause CF. Related stories Adult Day Program upgrades create more welc